Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Central serous chorioretinopathy complicating systemic corticosteroid treatment.

Literature DB >> 6712911

Central serous chorioretinopathy complicating systemic corticosteroid treatment.

Abstract

Central serous chorioretinopathy developed in 2 cases of retrobulbar neuritis during systemic treatment with corticosteroids. Fluorescein angiography confirmed leakage surrounded by central serous detachment of the retina. In one case the central serous chorioretinopathy recurred 3 times during 3 separate courses of treatment. Spontaneous recovery accompanied a reduction in steroid treatment to a low level. It is suggested that high dosage corticosteroids may damage the posterior blood-ocular barrier.

Entities: Chemical Disease

Mesh：

Substances：
Betamethasone

Year: 1984 PMID： 6712911 PMCID： PMC1040333 DOI： 10.1136/bjo.68.5.329

Source DB: PubMed Journal: Br J Ophthalmol ISSN： 0007-1161 Impact factor: 4.638

5 in total

1. Macular lesions during systemic therapy with depot tetracosactrin.

Authors: J Williamson; G Nuki
Journal: Br J Ophthalmol Date: 1970-06 Impact factor: 4.638

2. Central serous retinopathy and pregnancy.

Authors: L C Chumbley; R N Frank
Journal: Am J Ophthalmol Date: 1974-02 Impact factor: 5.258

3. Long-term follow-up of central serous retinopathy.

Authors: M Nanjiani
Journal: Trans Ophthalmol Soc U K Date: 1977-09

4. Maculopathy a corticosteroid side-effect.

Authors: I S Jain; K Singh
Journal: J All India Ophthalmol Soc Date: 1966-12

5. Experimental central serous chorioretinopathy in monkey eyes: fluorescein angiographic findings.

Authors: H Yoshioka; Y Katsume; H Akune
Journal: Ophthalmologica Date: 1982 Impact factor: 3.250

5 in total

26 in total

1. Crohn's disease complicated by central serous retinopathy.

Authors: G A Paspatis; P Koutentakis; K Triantafyllou; N Papanikolaoy; M Prinianaki; C Fanoyriakis
Journal: Dig Dis Sci Date: 2001-10 Impact factor: 3.199

2. Central serous chorioretinopathy after inhaled steroid use for post-mycoplasmal bronchospasm.

Authors: B Fardin; D J Weissgold
Journal: Br J Ophthalmol Date: 2002-09 Impact factor: 4.638

Review 3. Central serous retinopathy associated with adrenocorticotrophic hormone therapy. A case report and a hypothesis.

Authors: E Zamir
Journal: Graefes Arch Clin Exp Ophthalmol Date: 1997-06 Impact factor: 3.117

4. Central serous chorioretinopathy: to treat or not to treat?

Authors: J J De Laey
Journal: Doc Ophthalmol Date: 1986-01-15 Impact factor: 2.379

5. Finasteride is effective for the treatment of central serous chorioretinopathy.

Authors: E Moisseiev; A J Holmes; A Moshiri; L S Morse
Journal: Eye (Lond) Date: 2016-04-08 Impact factor: 3.775

Review 6. Central serous chorioretinopathy: update on pathophysiology and treatment.

Authors: Benjamin Nicholson; Jason Noble; Farzin Forooghian; Catherine Meyerle
Journal: Surv Ophthalmol Date: 2013 Mar-Apr Impact factor: 6.048

7. Long-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis).

Authors: Timothy Y Y Lai; Raymond L M Wong; Wai-Man Chan
Journal: Trans Am Ophthalmol Soc Date: 2015

8. Choroidal changes in eyes treated with high-dose systemic corticosteroids for optic neuritis.

Authors: Jun Hyuk Lee; Ji Young Lee; Ho Ra; Nam Yeo Kang; Jiwon Baek
Journal: Int J Ophthalmol Date: 2020-09-18 Impact factor: 1.779

9. Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level.

Authors: W-M Chan; D S C Lam; T Y Y Lai; B S M Tam; D T L Liu; C K M Chan
Journal: Br J Ophthalmol Date: 2003-12 Impact factor: 4.638

10. Central Serous Chorioretinopathy after Rhinoplasty.

Authors: Marilita M Moschos; Konstantinos Droutsas; Ioannis Margetis
Journal: Case Rep Ophthalmol Date: 2010-11-06